American Cancer Society Guidelines for Breast Cancer Screening: Update 2003

Authors


  • Author disclosures: Dr. Runowicz receives speaking fees and research support from Cytyc Corporation (First Cyte Ductal Lavage). Dr. Rubinstein is on the speaker's bureau for Myriad Genetic Laboratories, Inc. Dr. D'Orsi is a medical consultant to GE Medical Systems and R2 Technology, Inc. Dr. Feig is on the medical advisory board of R2 Technology, Inc., a company that sells a computer-aided detection device for mammography; he does not receive any financial remuneration or grant support from the company. Dr. Giger is a shareholder in R2 Technology, Inc.; she also has received unrestricted research support from the company in the past.

  • This article is available online at: http://CAonline.AmCancerSoc.org

Abstract

In 2003, the American Cancer Society updated its guidelines for early detection of breast cancer based on recommendations from a formal review of evidence and a recent workshop. The new screening recommendations address screening mammography, physical examination, screening older women and women with comorbid conditions, screening women at high risk, and new screening technologies.

Ancillary